116th Congress Could Test Cosmetic Industry’s Commitment To Reg Reform, Preemption Viability
This article was originally published in The Rose Sheet
Executive Summary
With Democrats in control of the House and New Jersey Rep. Frank Pallone in line for chair of the Energy & Commerce Committee, cosmetics regulatory reform legislation could receive even more attention in the 116th Congress than in the current session. The new climate could test how serious big business is about embracing large-scale changes as well as lawmakers’ openness to federal preemption.
You may also be interested in...
'Could Put Us Out Of Business’: US State Bill Pileup Has Small Beauty Set On Federal Preemption
The cosmetics industry has an “optics” problem, and that is creating other issues, namely a growing body of state legislation to address perceived gaps in federal regulatory oversight.
CIR Working To Highlight Expert Panel’s Independence Amid Mounting Pressures
The Cosmetic Ingredient Review says it expects to finalize a package of “advancements” in early 2020 to highlight the independence of its Expert Panel. Driven by the Personal Care Products Council-led CIR Steering Committee, the initiative comes at a time of escalating NGO criticism and legislative proposals that would undermine the CIR program and put its future in question.
Rep. Pallone’s Discussion Draft For Cosmetics Reform Closely Mirrors Reintroduced Feinstein/Collins Bill
A bipartisan proposal from new House Energy & Commerce chair Frank Pallone and Rep. John Shimkus, R-Ill., is a near-facsimile of the reintroduced Personal Care Products Safety Act in the Senate. This could set the stage for simultaneous consideration and expeditious movement in both chambers of Congress.